Graft
Graft, founded in 2021 and headquartered in the United States, operates in the machine learning and artificial intelligence sector.
Profile
Graft's current business activities are unconfirmed; the company's domain is listed for sale, indicating it may no longer be operational.
Graft, founded in 2021 and headquartered in the United States, operates in the machine learning and artificial intelligence sector. The company's website, graft.com, currently displays a notice indicating the domain is for sale, with an inquiry link to a third-party domain marketplace. This suggests that Graft may no longer be actively operating under this domain or has pivoted its business model.
No verifiable information about Graft's products, funding rounds, revenue, headcount, customer base, or leadership could be found in the provided research dossier or through publicly available sources. The dossier contains links to unrelated companies such as H.B. Fuller, Medtronic, Southern Company, and Johnson & Johnson, which are not associated with Graft.
Additionally, news articles about Yahoo selling TechCrunch and a Reuters video on AI funding jitters do not reference Graft. As of the research cutoff date of June 5, 2026, there is no credible, independent reporting or official disclosure that confirms Graft's operational status, product offerings, or financial trajectory. The company appears to have minimal to no public footprint, raising questions about its current viability or whether it has ceased operations. This profile reflects the available data, which is insufficient to provide a substantive overview of Graft's market position or activities.
Who buys this
- Unknown; no customer segments can be identified from available data.
- Unknown; no customer segments can be identified from available data.
- Unknown; no customer segments can be identified from available data.
Strengths and what to watch
Strengths
- No verifiable strengths can be assessed due to lack of public information.
- No verifiable strengths can be assessed due to lack of public information.
- No verifiable strengths can be assessed due to lack of public information.
Watch for
- Domain listed for sale on a third-party marketplace, suggesting potential business closure or pivot.
- Complete absence of independent news coverage, funding announcements, or product launches since founding in 2021.
- No verifiable revenue, headcount, or customer data available, indicating a lack of operational transparency.
Key Information
- Industry
- Enterprise ML Platforms
- Founded
- 2021
Frequently Asked Questions
What is Graft and what does it do?
Graft was founded in 2021 and operates in the machine learning and artificial intelligence sector. However, its current business activities are unconfirmed, and its domain is listed for sale, suggesting it may no longer be operational.
Is Graft still in business?
Graft's current operational status is unclear. The company's website, graft.com, displays a notice that the domain is for sale, which indicates Graft may no longer be actively operating or has pivoted its business model.
Why is Graft's domain listed for sale?
Graft's domain, graft.com, is listed for sale on a third-party marketplace. This suggests the company may have ceased operations or changed its business focus, as no active company website or verifiable products are available.
What products or services does Graft offer?
No verifiable information about Graft's products, funding rounds, revenue, headcount, customer base, or leadership could be found in publicly available sources. The company appears to have minimal to no public footprint.
Who founded Graft and where is it headquartered?
Graft was founded in 2021 and is headquartered in the United States. However, no specific details about its founders or leadership team are available from credible public sources or independent reporting.
Are there any news articles or funding announcements about Graft?
There is no independent news coverage, funding announcements, or product launches for Graft since its founding in 2021. The research dossier contains unrelated articles that do not reference the company.
Sources
- graft.com — Domain is listed for sale via a third-party marketplace, not an active company website.
- investors.hbfuller.com — Unrelated company H.B. Fuller; no connection to Graft.
- news.medtronic.com — Unrelated company Medtronic; no connection to Graft.
- www.reuters.com — News about Yahoo selling TechCrunch; no mention of Graft.